Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Off By 20 Points. More details...
CBT 220 Adds to Last Week's Gains. More details...
CBT 200 Drops 11 Points. More details...
Disease Is Less Common, But Deadly. More details...
Biotech Takes Third Loss in a Row. More details...
Clinical Trials Start Next Year. More details...
Several Biotechs Close Financing Rounds. More details...
While an Influenza Pandemic Is On Everyone's Mind. More...
Some Thoughts On The Pandemic To Come. More details...
CBT 200 Gives Up 13 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
